Evidence mapPaperPMID 39722067Full record

Observational studyFrontiers of medicine2025

Gallstones, cholecystectomy, and cancer risk: an observational and Mendelian randomization study.

Yuanyue Zhu, Linhui Shen, Yanan Huo, Qin Wan, Yingfen Qin, Ruying Hu, Lixin Shi, Qing Su, Xuefeng Yu, Li Yan and 30 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Frontiers of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Eravacycline: evaluation of susceptibility testing methods and activity against multidrug-resistant Enterobacterales and Acinetobacter.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Yuanyue Zhu *Department of Geriatrics, Medical Center on Aging, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Linhui Shen *Department of Geriatrics, Medical Center on Aging, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Yanan HuoJiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, 330006, China.
Qin WanThe Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
Yingfen QinThe First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Ruying HuZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Lixin ShiAffiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
Qing SuXinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Xuefeng YuTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Li YanSun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
Guijun QinThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Xulei TangThe First Hospital of Lanzhou University, Lanzhou, 730000, China.
Gang ChenFujian Provincial Hospital, Fujian Medical University, Fuzhou, 350003, China.
Yu XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Tiange WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhiyun ZhaoDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhengnan GaoDalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, 116033, China.
Guixia WangThe First Hospital of Jilin University, Changchun, 130021, China.
Feixia ShenThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Xuejiang GuThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zuojie LuoThe First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Li ChenQilu Hospital of Shandong University, Jinan, 250012, China.
Qiang LiThe Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Zhen YeZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Yinfei ZhangCentral Hospital of Shanghai Jiading District, Shanghai, 201899, China.
Chao LiuJiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, 210028, China.
Youmin WangThe First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Shengli WuKaramay Municipal People's Hospital, Karamay, 834000, China.
Tao YangThe First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Huacong DengThe First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Lulu ChenUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Tianshu ZengUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Jiajun ZhaoShandong Provincial Hospital affiliated to Shandong University, Jinan, 250012, China.
Yiming MuChinese People's Liberation Army General Hospital, Beijing, 100853, China.
Weiqing WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Guang NingDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Jieli LuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Min XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. della.xumin@shsmu.edu.cn.
Yufang BiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. byf10784@rjh.com.cn.
Weiguo HuDepartment of Geriatrics, Medical Center on Aging, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. wghu@rjh.com.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to comprehensively examine the association of gallstones, cholecystectomy, and cancer risk. Multivariable logistic regressions were performed to estimate the observational associations of gallstones and cholecystectomy with cancer risk, using data from a nationwide cohort involving 239 799 participants. General and gender-specific two-sample Mendelian randomization (MR) analysis was further conducted to assess the causalities of the observed associations. Observationally, a history of gallstones without cholecystectomy was associated with a high risk of stomach cancer (adjusted odds ratio (aOR)=2.54, 95% confidence interval (CI) 1.50-4.28), liver and bile duct cancer (aOR=2.46, 95% CI 1.17-5.16), kidney cancer (aOR=2.04, 95% CI 1.05-3.94), and bladder cancer (aOR=2.23, 95% CI 1.01-5.13) in the general population, as well as cervical cancer (aOR=1.69, 95% CI 1.12-2.56) in women. Moreover, cholecystectomy was associated with high odds of stomach cancer (aOR=2.41, 95% CI 1.29-4.49), colorectal cancer (aOR=1.83, 95% CI 1.18-2.85), and cancer of liver and bile duct (aOR=2.58, 95% CI 1.11-6.02). MR analysis only supported the causal effect of gallstones on stomach, liver and bile duct, kidney, and bladder cancer. This study added evidence to the causal effect of gallstones on stomach, liver and bile duct, kidney, and bladder cancer, highlighting the importance of cancer screening in individuals with gallstones.

Indexed as

CholecystectomyGallstonesNeoplasmsAdultAgedFemaleHumansMaleMendelian Randomization AnalysisMiddle AgedRisk FactorsStomach Neoplasmscancer riskcholecystectomygallstoneMendelian randomization

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.